TRACY HAWKINS: Open Payments
NPI 1477051720 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 30 payments from 6 companies in 2025. Trend: 2023 $142 · 2024 $730 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $193 |
| Corium, LLC | 10 | $147 |
| Axsome Therapeutics, Inc. | 3 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $22 |
Products named: TRINTELLIX, Azstarys, Auvelity, REXULTI, CAPLYTA, Quviviq.
Industry payments across CO — which companies pay providers there.
